Cargando…

Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores

Background: Cognitive impairment is poorly addressed in G8 screening. The aim of the present study was to evaluate the additional value of Mini-Cog© in urogeriatric patients concurrently screened by G8 scores. Methods: Seventy-four consecutive urogeriatric patients aged 75 and above were evaluated....

Descripción completa

Detalles Bibliográficos
Autores principales: Bouzan, Jobar, Willschrei, Peter, Horstmann, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608063/
https://www.ncbi.nlm.nih.gov/pubmed/37887263
http://dx.doi.org/10.3390/medicines10100056
_version_ 1785127690711334912
author Bouzan, Jobar
Willschrei, Peter
Horstmann, Marcus
author_facet Bouzan, Jobar
Willschrei, Peter
Horstmann, Marcus
author_sort Bouzan, Jobar
collection PubMed
description Background: Cognitive impairment is poorly addressed in G8 screening. The aim of the present study was to evaluate the additional value of Mini-Cog© in urogeriatric patients concurrently screened by G8 scores. Methods: Seventy-four consecutive urogeriatric patients aged 75 and above were evaluated. All patients underwent G8 and Mini-Cog© screening. Patients with a G8 score above 14 were considered geriatric “healthy or fit”. A Mini-Cog© from four to five points was considered inconspicuous in screening for cognitive impairment. The additional information of a Mini-Cog© screening during G8 screening was evaluated by looking at G8 “fit and healthy” patients who had conspicuous Mini-Cog© tests and vice versa. Additionally, the results of the neuropsychological subitem “E” of the G8 score were compared with the results of the Mini-Cog© screening. Results: The mean age of the patients was 83 y (min. 75–max. 102). Sixty-one of the patients were males, and 13 were females. Twenty-nine of the patients had a normal G8 score and were considered “healthy or fit”, and 45 were not. Forty-three of the patients had an inconspicuous Mini-Cog©, and 31 had a conspicuous Mini-Cog© of less than four points. The majority of G8 “healthy or fit” patients (n = 24/29) had an inconspicuous Mini-Cog© test. However, of them, five patients had a Mini-Cog© of less than four points, which is suspicious for cognitive disorders. Furthermore, of the 43 patients with a normal G8 subscore in item “E” of two points, 6 patients had a conspicuous Mini-Cog© of less than four points. Conclusions: As shown by the present study, the Mini-Cog© might extend the G8 screening with regard to the detection of cognitive functional impairments that are not detected by the G8 screening alone. It can be easily added to G8 screening.
format Online
Article
Text
id pubmed-10608063
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106080632023-10-28 Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores Bouzan, Jobar Willschrei, Peter Horstmann, Marcus Medicines (Basel) Brief Report Background: Cognitive impairment is poorly addressed in G8 screening. The aim of the present study was to evaluate the additional value of Mini-Cog© in urogeriatric patients concurrently screened by G8 scores. Methods: Seventy-four consecutive urogeriatric patients aged 75 and above were evaluated. All patients underwent G8 and Mini-Cog© screening. Patients with a G8 score above 14 were considered geriatric “healthy or fit”. A Mini-Cog© from four to five points was considered inconspicuous in screening for cognitive impairment. The additional information of a Mini-Cog© screening during G8 screening was evaluated by looking at G8 “fit and healthy” patients who had conspicuous Mini-Cog© tests and vice versa. Additionally, the results of the neuropsychological subitem “E” of the G8 score were compared with the results of the Mini-Cog© screening. Results: The mean age of the patients was 83 y (min. 75–max. 102). Sixty-one of the patients were males, and 13 were females. Twenty-nine of the patients had a normal G8 score and were considered “healthy or fit”, and 45 were not. Forty-three of the patients had an inconspicuous Mini-Cog©, and 31 had a conspicuous Mini-Cog© of less than four points. The majority of G8 “healthy or fit” patients (n = 24/29) had an inconspicuous Mini-Cog© test. However, of them, five patients had a Mini-Cog© of less than four points, which is suspicious for cognitive disorders. Furthermore, of the 43 patients with a normal G8 subscore in item “E” of two points, 6 patients had a conspicuous Mini-Cog© of less than four points. Conclusions: As shown by the present study, the Mini-Cog© might extend the G8 screening with regard to the detection of cognitive functional impairments that are not detected by the G8 screening alone. It can be easily added to G8 screening. MDPI 2023-10-08 /pmc/articles/PMC10608063/ /pubmed/37887263 http://dx.doi.org/10.3390/medicines10100056 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Bouzan, Jobar
Willschrei, Peter
Horstmann, Marcus
Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores
title Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores
title_full Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores
title_fullStr Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores
title_full_unstemmed Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores
title_short Additional Value of Mini-Cog© in Urogeriatric Patients Concurrently Screened by G8 Scores
title_sort additional value of mini-cog© in urogeriatric patients concurrently screened by g8 scores
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608063/
https://www.ncbi.nlm.nih.gov/pubmed/37887263
http://dx.doi.org/10.3390/medicines10100056
work_keys_str_mv AT bouzanjobar additionalvalueofminicoginurogeriatricpatientsconcurrentlyscreenedbyg8scores
AT willschreipeter additionalvalueofminicoginurogeriatricpatientsconcurrentlyscreenedbyg8scores
AT horstmannmarcus additionalvalueofminicoginurogeriatricpatientsconcurrentlyscreenedbyg8scores